Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia

✍ Scribed by Walzer, S.; Tournier, C.; Marino, J.P.; Mueller, E.; Duong, M.

• Book ID: 122306998
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 78 KB
• Volume: 16
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2013.08.448